2025-07-25 - Analysis Report
Okay, here's the analysis of Newmont Corporation (NEM), incorporating all the data you provided.  The report is in English with numerical data highlighted, followed by analysis.

## Newmont Corporation (NEM) Analysis

**Ticker:** NEM
**Company Name:** Newmont Corporation
**Description:** Newmont Corporation is one of the world's leading gold producers with significant operations and projects in North America, South America, Australia, and Africa.

### 1. Performance vs. S&P 500 (VOO)

*   **NEM Cumulative Return:** 33.96%
*   **VOO Cumulative Return:** 98.88%
*   **Absolute Divergence:** -62.8
*   **Divergence Range:** Max: 90.2, Min: -83.6
*   **Relative Divergence:** 12.0

**Analysis:** NEM has significantly underperformed the S&P 500 (VOO) over the observed period. The absolute divergence is substantial (-62.8%), indicating a considerable gap in returns. The relative divergence of 12.0 suggests that NEM's underperformance is near the lower end of its historical range relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2015-2017  | 33.0%   | 26.5%   | 4.0%    | -0.0  | 41.8   |
| 2016-2018  | 17.0%   | 58.8%   | -1.0%   | 0.0   | 38.6   |
| 2017-2019  | -2.0%   | 58.8%   | -31.0%  | -0.1  | 48.4   |
| 2018-2020  | 34.0%   | 58.8%   | 15.0%   | 0.0   | 66.7   |
| 2019-2021  | 72.0%   | 59.9%   | 23.0%   | 0.1   | 69.0   |
| 2020-2022  | -14.0%  | 64.3%   | -17.0%  | 0.1   | 52.5   |
| 2021-2023  | -44.0%  | 71.4%   | -62.0%  | 0.5   | 46.1   |
| 2022-2024  | -74.0%  | 75.3%   | -99.0%  | 0.8   | 41.4   |
| 2023-2025  | -12.0%  | 75.3%   | -63.0%  | 1.4   | 68.5   |

**Analysis:**

*   **CAGR & MDD:** Recent years show negative Compound Annual Growth Rate (CAGR) coupled with high Maximum Drawdown (MDD), indicating significant losses and volatility.
*   **Alpha:** Alpha is overwhelmingly negative in recent periods, indicating significant underperformance relative to its benchmark.
*   **Beta:** Beta is low in earlier years, suggesting low correlation with the market.  However, Beta has increased significantly in recent years, implying a higher correlation with market movements and increased sensitivity to market risk.
*   **Market Cap:** The market capitalization (Cap(B)) has fluctuated, but remains substantial, reflecting Newmont's position as a major player in its industry.

### 2. Recent Price Action

*   **Last Price:** 61.51
*   **Previous Close:** 61.42
*   **Change:** 0.15
*   **5-Day Moving Average:** 60.536
*   **20-Day Moving Average:** 59.3317
*   **60-Day Moving Average:** 55.6824

**Analysis:** The current price is slightly higher than the previous close, indicating a small upward movement.  The moving averages show an upward trend (5-day > 20-day > 60-day), suggesting short-term bullish momentum.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3274 (Low Risk)
*   **RSI:** 55.41
*   **PPO:** 0.1163
*   **Hybrid Signal:** cash_1%_Buy 90% of cash (172 shares - Safe - MRI:0.33) (Cash Ratio: 1% on 2025-07-24)
*   **Delta (20-day Relative Divergence Change):** 0.6 (+) - Short-term Increase
*   **Expected Return:** -147.0%

**Analysis:**

*   **MRI:** The Market Risk Indicator is in the "Low Risk" range.
*   **RSI:** RSI is at 55.41, indicating neutral momentum, not overbought or oversold.
*   **PPO:** The PPO is positive (0.1163), suggesting a slightly bullish trend.
*   **Hybrid Signal:** The hybrid signal suggests a conservative buy strategy, allocating 90% of available cash to purchase shares, maintaining a 1% cash reserve. This is considered a "Safe" signal given the MRI.
*   **Delta:** The increase in relative divergence (0.6) over the past 20 days suggests a recent period of short-term outperformance relative to its benchmark.
*   **Expected Return:** The very negative expected return (-147.0%) is a major concern. It suggests a highly pessimistic outlook for NEM's long-term performance relative to the S&P 500 if a buy-and-hold strategy is employed.
*   **Price Change:** The small price change indicates only a minor issue.

### 4. Recent News & Significant Events

*   **[2025-07-23]** Major business developments, regulatory changes, or market events impacting Newmont Corporation.
*   **[2025-07-22]** Analyst discussions on Newmont Corporation's recent performance and outlook.
*   **[2025-07-21]** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-24]** Market experts highlighting both risks and opportunities.

**Analysis:** The news snippets point to ongoing developments, analyst scrutiny, volatility, and a mix of risks and opportunities. Investors should closely monitor company announcements and market trends.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue       |
| :--------- | :--- | :------------ |
| 2025-07-24 | 1.86 | 5.32 B$       |
| 2025-04-24 | 1.68 | 5.01 B$       |
| 2024-10-24 | 0.8  | 4.61 B$       |
| 2024-07-25 | 0.74 | 4.40 B$       |
| 2025-07-24 | 0.74 | 4.40 B$       |

**Analysis:**
*   EPS: EPS(Earn Per Share) has been in increasing trend, but the last one is same with 1 year ago
*   Revenue: Revenue also has been in increasing trend, but the last one is same with 1 year ago

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-03-31 | $5.01B    | 46.13%        |
| 2024-12-31 | $5.65B    | 45.51%        |
| 2024-09-30 | $4.61B    | 36.13%        |
| 2024-06-30 | $4.40B    | 37.35%        |
| 2024-03-31 | $4.02B    | 31.39%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
| :--------- | :-------- | :------ |
| 2025-03-31 | $31.25B   | 6.05%   |
| 2024-12-31 | $29.93B   | 4.69%   |
| 2024-09-30 | $29.71B   | 3.10%   |
| 2024-06-30 | $29.38B   | 2.90%   |
| 2024-03-31 | $28.89B   | 0.59%   |

**Analysis:**

*   **Revenue & Profit Margin:** Revenue shows some variability, with the highest revenue in 2024-12-31. Profit margins are relatively healthy, ranging from 31.39% to 46.13%.
*   **Equity & ROE:** Equity has steadily increased over the quarters. Return on Equity (ROE) has also improved significantly, indicating better profitability relative to equity.

### 7. Overall Analysis

Newmont Corporation (NEM) presents a mixed picture. While recent earnings and financial data show improvements in revenue, profit margins, and ROE, the stock has significantly underperformed the S&P 500, and its long-term expected return is highly negative. The increased beta suggests greater sensitivity to market movements. Recent news indicates ongoing developments and analyst scrutiny, suggesting potential volatility.

**Key Takeaways:**

*   **Underperformance:** Substantial underperformance relative to the S&P 500 is a major concern.
*   **Improving Financials:** Recent financial data (earnings, revenue, ROE) show positive trends.
*   **Technical Signals:** Technical indicators (RSI, PPO) are currently neutral to slightly bullish.
*   **Risk Factors:** Negative expected return and recent news suggest caution is warranted.

**Recommendation:**

Given the significant underperformance and negative expected return, a conservative approach is advised. While recent financial improvements and the low MRI are encouraging, the risks outweigh the potential rewards at this time. Further research and monitoring of company announcements and market trends are crucial before making any investment decisions.
